TY  - GEN
AU  - Tello-Montoliu,Antonio
AU  - Albaladejo,Paula
AU  - Hernández-Romero,Diana
AU  - Taboada,Ruben
AU  - Albacete,Carlos L
AU  - Arribas,José María
AU  - Jara,Ruben
AU  - Veliz,Andrea
AU  - López-García,Cecilia
AU  - Cánovas,Sergio
AU  - Valdés,Mariano
AU  - Rivera-Caravaca,José Miguel
AU  - Marín,Francisco
TI  - Bleeding Risk Prediction in Patients With Dual Antiplatelet Therapy Undergoing Coronary Artery Bypass Grafting Surgery Using a Rapid Point-of-Care Platelet Function Test
SN  - 1941-7632
PY  - 2019///1101
KW  - Acute Coronary Syndrome
KW  - blood
KW  - Aged
KW  - Aspirin
KW  - administration & dosage
KW  - Clinical Decision-Making
KW  - Coronary Artery Bypass
KW  - adverse effects
KW  - Drug Therapy, Combination
KW  - Female
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Patient Selection
KW  - Platelet Aggregation Inhibitors
KW  - Platelet Function Tests
KW  - Point-of-Care Testing
KW  - Postoperative Hemorrhage
KW  - chemically induced
KW  - Predictive Value of Tests
KW  - Prospective Studies
KW  - Purinergic P2Y Receptor Antagonists
KW  - Reproducibility of Results
KW  - Risk Assessment
KW  - Risk Factors
KW  - Treatment Outcome
N1  - Publication Type: Letter; Observational Study; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1161/CIRCINTERVENTIONS.118.007264
ER  -